SectorPharmaceutical
Established Date09/01/2018
Listing Date25/10/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees371
Fiscal Year Ends31/12
Security TypeCommon stock
Office address100 Campus Drive
, Suite 102
, Florham Park
, New Jersey 07932
Business
IntroductionPhathom Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on January 9, 2018. The Company is a biopharmaceutical company focused on the development and commercialization of new therapies for the treatment of gastrointestinal diseases or GI diseases. The Company's approved products include VOQUEZNA, VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK, all of which contain vonoprazan, an oral small molecule potassium ion competitive acid blocker (PCAB). PCAB is a new class of molecules that inhibit gastric acid secretion. VOQUEZNA is currently the only PCAB approved for sale in the United States.
